Angiotensin-(1-7) reverses angiogenic dysfunction in corpus cavernosum by acting on the microvasculature and bone marrow-derived cells in diabetes.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Sexual Medicine

• Publication date

  2014-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/jsm.12620PMID 24953642PMCID PMC4149830
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Restoring stem cell mobilization to promote vascular repair in diabetes.

  2013cited by this paper
• Pathophysiological role of the renin–angiotensin system on erectile dysfunction

  2013cited by this paper
• AVE 0991, a non‐peptide Mas‐receptor agonist, facilitates penile erection

  2013cited by this paper
• Regulatory Systems in Bone Marrow for Hematopoietic Stem/Progenitor Cells Mobilization and Homing

  2013cited by this paper
• Diabetes Impairs Stem Cell and Proangiogenic Cell Mobilization in Humans

  2013cited by this paper
• Role of angiotensin II and angiotensin-(1-7) in diabetes-induced oxidative DNA damage in the corpus cavernosum.

  2013cited by this paper
• Activation of the ACE2/Angiotensin-(1–7)/Mas Receptor Axis Enhances the Reparative Function of Dysfunctional Diabetic Endothelial Progenitors

  2013cited by this paper
• Angiotensin-Converting Enzyme 2 Priming Enhances the Function of Endothelial Progenitor Cells and Their Therapeutic Efficacy

  2013cited by this paper
• Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches.

  2013cited by this paper
• Angiopoietins in angiogenesis.

  2013cited by this paper
• An oral formulation of angiotensin-(1-7) reverses corpus cavernosum damages induced by hypercholesterolemia.

  2013cited by this paper
• Stem Cell Therapy for Erectile Dysfunction: A Critical Review

  2012cited by this paper
• Matrigel-based sprouting endothelial cell culture system from mouse corpus cavernosum is potentially useful for the study of endothelial and erectile dysfunction related to high-glucose exposure.

  2012cited by this paper
• Strategies for enhancing progenitor cell mobilization and function in diabetes.

  2012cited by this paper
• Mobilization of stem and progenitor cells in cardiovascular diseases

  2012cited by this paper
• The therapeutic role of VEGF-expressing muscle-derived stem cells in acute penile cavernosal injury.

  2012cited by this paper
• New Cardiovascular and Pulmonary Therapeutic Strategies Based on the Angiotensin-Converting Enzyme 2/Angiotensin-(1–7)/Mas Receptor Axis

  2012cited by this paper
• Effects of intravenous injection of adipose-derived stem cells in a rat model of radiation therapy-induced erectile dysfunction.

  2012cited by this paper
• Differential activity of bone marrow hematopoietic stem cell subpopulations for EPC development and ischemic neovascularization.

  2011cited by this paper
• ACE2–angiotensin-(1–7)–Mas axis and oxidative stress in cardiovascular disease

  2011cited by this paper
• Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges.

  2011cited by this paper
• Blockade of NADPH oxidase restores vasoreparative function in diabetic CD34+ cells.

  2011cited by this paper
• Oxidative stress and diabetic complications.

  2010cited by this paper
• The RAGE Axis: A Fundamental Mechanism Signaling Danger to the Vulnerable Vasculature [2010;106:842–853] The Promise of Cell-Based Therapies for Diabetic Complications: Challenges and Solutions Oxidative Stress and Diabetic Complications The Polyol Pathway: Implications for Atherosclerosis and Cardi

  2010cited by this paper
• CXCL12-CXCR4 axis in angiogenesis, metastasis and stem cell mobilization.

  2010cited by this paper
• Bone marrow-derived cells and hypertension

  2010cited by this paper
• The promise of cell-based therapies for diabetic complications: challenges and solutions.

  2010cited by this paper
• Circulating Rather Than Cardiac Angiotensin-(1-7) Stimulates Cardioprotection After Myocardial Infarction

  2010cited by this paper
• Defining the potential for cell therapy for vascular disease using animal models

  2009cited by this paper
• The relative potency and safety of endothelial progenitor cells and unselected mononuclear cells for recovery from myocardial infarction and ischemia

  2009cited by this paper
• Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor

  2009cited by this paper
• Ancestral vascular tube formation and its adoption by tumors

  2009cited by this paper
• Differential function of Tie2 at cell–cell contacts and cell–substratum contacts regulated by angiopoietin-1

  2008cited by this paper
• Recent advances in the angiotensin‐converting enzyme 2–angiotensin(1–7)–Mas axis

  2008cited by this paper
• Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis

  2008cited by this paper
• Angiotensin-(1-7) as an antihypertensive, antifibrotic target

  2008cited by this paper
• Evidence that the vasodilator angiotensin-(1-7)-Mas axis plays an important role in erectile function.

  2007cited by this paper
• Ischemic Vascular Damage Can Be Repaired by Healthy, but Not Diabetic, Endothelial Progenitor Cells

  2007cited by this paper
• Downregulation of angiogenic factors and their downstream target molecules affects the deterioration of erectile function in a rat model of hypercholesterolemia

  2006cited by this paper
• Downregulation of angiogenic factors and their downstream target molecules affects the deterioration of erectile function in a rat model of hypercholesterolemia.

  2006cited by this paper
• Obese Diabetic Mouse Environment Differentially Affects Primitive and Monocytic Endothelial Cell Progenitors

  2005cited by this paper
• SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells.

  2004cited by this paper
• Molecular pathways regulating mobilization of marrow-derived stem cells for tissue revascularization.

  2003cited by this paper
• Endothelial dysfunction in erectile dysfunction: role of the endothelium in erectile physiology and disease.

  2003cited by this paper
• ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors.

  2002cited by this paper
• Mechanisms of angiotensin-(1-7)-induced inhibition of angiogenesis.

  2001cited by this paper
• Role of vascular endothelial growth factor in diabetic vascular complications.

  2000cited by this paper
• Erectile dysfunction in type 1 and type 2 diabetics in Italy. On behalf of Gruppo Italiano Studio Deficit Erettile nei Diabetici.

  2000cited by this paper
• Therapeutic Angiogenesis: A New Frontier for Vascular Therapy

  1996cited by this paper
• Prevalence of Self-Reported Erectile Dysfunction in People With Long-Term IDDM

  1996cited by this paper
• Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence.

  1989cited by this paper

• Alamandine/MrgD Pathway Modulates Gut-Bone Marrow Axis in Aging

  2026cites this paper
• Restoration of the gut barrier integrity and restructuring of the gut microbiome in aging by Angiotensin-(1-7).

  2023cites this paper
• Angiotensin-(1-7) improves diabetes mellitus-induced erectile dysfunction in rats by regulating nitric oxide synthase levels.

  2022cites this paper
• ACE2 gene transfer ameliorates vasoreparative dysfunction in CD34+ cells derived from diabetic older adults

  2021cites this paper
• Targeting ACE2/Angiotensin-(1-7)/Mas Receptor Axis in the Vascular Progenitor Cells for Cardiovascular Diseases.

  2020cites this paper
• Effect of angiotensin II and angiotensin‐(1–7) on proliferation of stem cells from human dental apical papilla

  2020cites this paper
• ACE2/ACE imbalance and impaired vasoreparative functions of stem/progenitor cells in aging

  2020cites this paper
• Angiotensin-converting enzyme 2 (ACE2), angiotensin-(1-7) and Mas receptor in gonadal and reproductive functions.

  2020cites this paper
• Angiotensin-(1-7) improves Islet Function in a Rat Model of Streptozotocin-induced Diabetes Mellitus by Up-regulating the Expression of Pdx1/Glut2.

  2020cites this paper
• The role of receptor MAS in microglia-driven retinal vascular development

  2019cites this paper
• A Study of the Correlation between Angiotensin (1-7) and the Histopathological Changes in the Penises of Experimentally Diabetic Rats

  2018cites this paper
• Methods for Studying the Role of RAAS in the Modulation of Vascular Repair-Relevant Functions of Stem/Progenitor Cells.

  2017cites this paper
• Angiotensin-(1-7): A Target for Stem Cell Mobilopathy and Vascular Repair in Diabetes

  2017influential citation
• Mechanisms of Mas1 Receptor-Mediated Signaling in the Vascular Endothelium

  2017cites this paper
• MiR-145 functions as a tumor suppressor via regulating angiopoietin-2 in pancreatic cancer cells

  2016cites this paper
• Impaired Mobilization of Vascular Reparative Bone Marrow Cells in Streptozotocin-Induced Diabetes but not in Leptin Receptor-Deficient db/db Mice

  2016cites this paper
• Angiotensin converting enzyme versus angiotensin converting enzyme-2 selectivity of MLN-4760 and DX600 in human and murine bone marrow-derived cells.

  2016cites this paper
• Could angiotensin-(1-7) be connected with improvement of microvascular function in diabetic patients? Angiotensin-(1-7) iontophoresis may provide the answer.

  2016cites this paper
• Reversal of Bone Marrow Mobilopathy and Enhanced Vascular Repair by Angiotensin-(1-7) in Diabetes

  2016cites this paper